Regulus Therapeutics Inc. Quarterly Interest Expense in USD from Q3 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regulus Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from Q3 2011 to Q1 2024.
  • Regulus Therapeutics Inc. Interest Expense for the quarter ending March 31, 2024 was $81K, a 56.2% decline year-over-year.
  • Regulus Therapeutics Inc. Interest Expense for the twelve months ending March 31, 2024 was $500K, a 30.4% decline year-over-year.
  • Regulus Therapeutics Inc. annual Interest Expense for 2023 was $604K, a 12.2% decline from 2022.
  • Regulus Therapeutics Inc. annual Interest Expense for 2022 was $688K, a 19.5% decline from 2021.
  • Regulus Therapeutics Inc. annual Interest Expense for 2021 was $855K, a 52.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $500K $81K -$104K -56.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $604K $114K -$82K -41.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $686K $137K -$38K -21.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $724K $168K +$6K +3.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $718K $185K +$30K +19.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $688K $196K -$17K -7.98% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $705K $175K -$35K -16.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $740K $162K -$54K -25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $794K $155K -$61K -28.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $855K $213K -$179K -45.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $1.03M $210K -$256K -54.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.29M $216K -$245K -53.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.54M $216K -$273K -55.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $1.81M $392K -$106K -21.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $1.91M $466K -$51K -9.87% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.97M $461K -$77K -14.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $2.04M $489K -$89K -15.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.13M $498K +$1K +0.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $2.13M $517K -$103K -16.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.23M $538K -$83K -13.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $2.32M $578K -$27K -4.46% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $2.34M $497K -$497K -50% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2.84M $620K +$40K +6.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.8M $621K +$18K +2.99% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.78M $605K +$59K +10.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.72M $994K +$486K +95.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $2.24M $580K +$20K +3.57% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.22M $603K +$513K +570% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.7M $546K +$522K +2175% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.18M $508K +$477K +1539% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $705K $560K +$554K +9233% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $151K $90K +$83K +1186% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $68K $24K +$16K +200% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $52K $31K +$23K +288% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $29K $6K -$4K -40% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $33K $7K -$3K -30% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $36K $8K -$3K -27.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $39K $8K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 $10K +$3K +42.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $10K -$8K -44.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $11K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q3 2013 $7K -$103K -93.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $18K -$72K -80% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q4 2012 $247K -$46K Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $110K +$13K +13.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $90K Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-16
Q1 2012 $93K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $97K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.